- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Contract Pharmaceutical Manufacturing market will register a 6.1% CAGR in terms of revenue, the global market size will reach $ 96200 million by 2025, from $ 75850 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Contract Pharmaceutical Manufacturing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Contract Pharmaceutical Manufacturing market by type, application, key manufacturers and key regions and countries.
This study considers the Contract Pharmaceutical Manufacturing value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
API
FDF
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Specialty/Midsize
Generics
Big Pharma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Catalent
AbbVie
DPx
Piramal Healthcare
Aenova
Lonza
Boehringer Ingelheim
Jubilant
Fareva Holding
Famar
NextPharma
Aesica
Dishman
Nipro Corp
DPT Laboratories
Sopharma
Recipharm
Vetter
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Contract Pharmaceutical Manufacturing consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Contract Pharmaceutical Manufacturing market by identifying its various subsegments.
Focuses on the key global Contract Pharmaceutical Manufacturing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Contract Pharmaceutical Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Contract Pharmaceutical Manufacturing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Contract Pharmaceutical Manufacturing Consumption 2015-2025
2.1.2 Contract Pharmaceutical Manufacturing Consumption CAGR by Region
2.2 Contract Pharmaceutical Manufacturing Segment by Type
2.2.1 API
2.2.2 FDF
2.3 Contract Pharmaceutical Manufacturing Consumption by Type
2.3.1 Global Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
2.3.2 Global Contract Pharmaceutical Manufacturing Revenue and Market Share by Type (2015-2020)
2.3.3 Global Contract Pharmaceutical Manufacturing Sale Price by Type (2015-2020)
2.4 Contract Pharmaceutical Manufacturing Segment by Application
2.4.1 Specialty/Midsize
2.4.2 Generics
2.4.3 Big Pharma
2.4.4 Other
2.5 Contract Pharmaceutical Manufacturing Consumption by Application
2.5.1 Global Contract Pharmaceutical Manufacturing Consumption Market Share by Type (2015-2020)
2.5.2 Global Contract Pharmaceutical Manufacturing Value and Market Share by Type (2015-2020)
2.5.3 Global Contract Pharmaceutical Manufacturing Sale Price by Type (2015-2020)
3 Global Contract Pharmaceutical Manufacturing by Company
3.1 Global Contract Pharmaceutical Manufacturing Sales Market Share by Company
3.1.1 Global Contract Pharmaceutical Manufacturing Sales by Company (2018-2020)
3.1.2 Global Contract Pharmaceutical Manufacturing Sales Market Share by Company (2018-2020)
3.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Company
3.2.1 Global Contract Pharmaceutical Manufacturing Revenue by Company (2018-2020)
3.2.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Company (2018-2020)
3.3 Global Contract Pharmaceutical Manufacturing Sale Price by Company
3.4 Global Contract Pharmaceutical Manufacturing Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Contract Pharmaceutical Manufacturing Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Contract Pharmaceutical Manufacturing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Contract Pharmaceutical Manufacturing by Regions
4.1 Contract Pharmaceutical Manufacturing by Regions
4.2 Americas Contract Pharmaceutical Manufacturing Consumption Growth
4.3 APAC Contract Pharmaceutical Manufacturing Consumption Growth
4.4 Europe Contract Pharmaceutical Manufacturing Consumption Growth
4.5 Middle East & Africa Contract Pharmaceutical Manufacturing Consumption Growth
5 Americas
5.1 Americas Contract Pharmaceutical Manufacturing Consumption by Countries
5.1.1 Americas Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020)
5.1.2 Americas Contract Pharmaceutical Manufacturing Value by Countries (2015-2020)
5.2 Americas Contract Pharmaceutical Manufacturing Consumption by Type
5.3 Americas Contract Pharmaceutical Manufacturing Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Contract Pharmaceutical Manufacturing Consumption by Regions
6.1.1 APAC Contract Pharmaceutical Manufacturing Consumption by Regions (2015-2020)
6.1.2 APAC Contract Pharmaceutical Manufacturing Value by Regions (2015-2020)
6.2 APAC Contract Pharmaceutical Manufacturing Consumption by Type
6.3 APAC Contract Pharmaceutical Manufacturing Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Contract Pharmaceutical Manufacturing by Countries
7.1.1 Europe Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020)
7.1.2 Europe Contract Pharmaceutical Manufacturing Value by Countries (2015-2020)
7.2 Europe Contract Pharmaceutical Manufacturing Consumption by Type
7.3 Europe Contract Pharmaceutical Manufacturing Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Contract Pharmaceutical Manufacturing by Countries
8.1.1 Middle East & Africa Contract Pharmaceutical Manufacturing Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Contract Pharmaceutical Manufacturing Value by Countries (2015-2020)
8.2 Middle East & Africa Contract Pharmaceutical Manufacturing Consumption by Type
8.3 Middle East & Africa Contract Pharmaceutical Manufacturing Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Contract Pharmaceutical Manufacturing Distributors
10.3 Contract Pharmaceutical Manufacturing Customer
11 Global Contract Pharmaceutical Manufacturing Market Forecast
11.1 Global Contract Pharmaceutical Manufacturing Consumption Forecast (2021-2025)
11.2 Global Contract Pharmaceutical Manufacturing Forecast by Regions
11.2.1 Global Contract Pharmaceutical Manufacturing Forecast by Regions (2021-2025)
11.2.2 Global Contract Pharmaceutical Manufacturing Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Contract Pharmaceutical Manufacturing Forecast by Type
11.8 Global Contract Pharmaceutical Manufacturing Forecast by Application
12 Key Players Analysis
12.1 Catalent
12.1.1 Company Information
12.1.2 Contract Pharmaceutical Manufacturing Product Offered
12.1.3 Catalent Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Catalent Latest Developments
12.2 AbbVie
12.2.1 Company Information
12.2.2 Contract Pharmaceutical Manufacturing Product Offered
12.2.3 AbbVie Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 AbbVie Latest Developments
12.3 DPx
12.3.1 Company Information
12.3.2 Contract Pharmaceutical Manufacturing Product Offered
12.3.3 DPx Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 DPx Latest Developments
12.4 Piramal Healthcare
12.4.1 Company Information
12.4.2 Contract Pharmaceutical Manufacturing Product Offered
12.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Piramal Healthcare Latest Developments
12.5 Aenova
12.5.1 Company Information
12.5.2 Contract Pharmaceutical Manufacturing Product Offered
12.5.3 Aenova Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Aenova Latest Developments
12.6 Lonza
12.6.1 Company Information
12.6.2 Contract Pharmaceutical Manufacturing Product Offered
12.6.3 Lonza Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Lonza Latest Developments
12.7 Boehringer Ingelheim
12.7.1 Company Information
12.7.2 Contract Pharmaceutical Manufacturing Product Offered
12.7.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Boehringer Ingelheim Latest Developments
12.8 Jubilant
12.8.1 Company Information
12.8.2 Contract Pharmaceutical Manufacturing Product Offered
12.8.3 Jubilant Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Jubilant Latest Developments
12.9 Fareva Holding
12.9.1 Company Information
12.9.2 Contract Pharmaceutical Manufacturing Product Offered
12.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Fareva Holding Latest Developments
12.10 Famar
12.10.1 Company Information
12.10.2 Contract Pharmaceutical Manufacturing Product Offered
12.10.3 Famar Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Famar Latest Developments
12.11 NextPharma
12.11.1 Company Information
12.11.2 Contract Pharmaceutical Manufacturing Product Offered
12.11.3 NextPharma Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 NextPharma Latest Developments
12.12 Aesica
12.12.1 Company Information
12.12.2 Contract Pharmaceutical Manufacturing Product Offered
12.12.3 Aesica Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Aesica Latest Developments
12.13 Dishman
12.13.1 Company Information
12.13.2 Contract Pharmaceutical Manufacturing Product Offered
12.13.3 Dishman Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Dishman Latest Developments
12.14 Nipro Corp
12.14.1 Company Information
12.14.2 Contract Pharmaceutical Manufacturing Product Offered
12.14.3 Nipro Corp Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Nipro Corp Latest Developments
12.15 DPT Laboratories
12.15.1 Company Information
12.15.2 Contract Pharmaceutical Manufacturing Product Offered
12.15.3 DPT Laboratories Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 DPT Laboratories Latest Developments
12.16 Sopharma
12.16.1 Company Information
12.16.2 Contract Pharmaceutical Manufacturing Product Offered
12.16.3 Sopharma Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Sopharma Latest Developments
12.17 Recipharm
12.17.1 Company Information
12.17.2 Contract Pharmaceutical Manufacturing Product Offered
12.17.3 Recipharm Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Recipharm Latest Developments
12.18 Vetter
12.18.1 Company Information
12.18.2 Contract Pharmaceutical Manufacturing Product Offered
12.18.3 Vetter Contract Pharmaceutical Manufacturing Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Vetter Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Contract Pharmaceutical Manufacturing Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
